Clinical Trials
Healthcare
Eli Lilly’s Zepbound Reduces Sleep Apnea in Obese Adults
Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...
Billionairesworld's billionaires
Feng Yuxia: Steering Joinn Laboratories Toward Global Leadership in Medical Services
In the ever-evolving landscape of global healthcare, few figures have made as indelible a mark as Feng Yuxia, the visionary chair of Joinn...
